Real World Evidence, a substitute for phase IV and late phase III clinical trials that could make earlier introduction of new medicines possible

• In: F11 - The value of real world evidence - will availability of data lead to a paradigm change? on Tuesday, 3 September 2013, 09.00-12.00
• At: Dublin (Ireland) (2013)
• Type: Presentation
• By: LEUFKENS, Bert (University of Utrecht , Netherlands)
The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login